The global regenerative medicine market is being driven by the rising incidences of bone replacement and other surgeries and the rapid advancement in the field of tissue engineering. The rise in the number of clinical trials, supported by both the government and private organisations, is further contributing to the market growth.
North America dominates the industry, accounting for a significant share in the global regenerative medicine market. The industry growth in the region can be attributed to the increased penetration of the key players, and the availability of advanced research institutes and technologies. Researchers supported by the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services, developed a clinical-grade stem cell line in 2016, having the ability to boost the advance of new medical applications and cell-based therapies for diseases like Alzheimer’s disease, Parkinson’s disease, spinal cord injury, diabetes, and muscular dystrophy. The Asia Pacific is expected be one of the major emerging markets for regenerative medicines over the forecast period owing to the rising population and increased government expenditure in the research sector.
Continuous development in the field of minimally invasive surgical (MIS) procedures by the manufacturers is leading to the increased prevalence of such surgeries, which will further drive the demand for regenerative medicines. In September 2019, Integra LifeSciences Holdings Corporation (NASDAQ: IART), a global leader in medical technology, announced the acquisition of Rebound Therapeutics, manufacturers of single-use medical devices with integrated optics and illumination capability, providing minimally invasive access for therapeutic and diagnostic use in neurosurgery. This acquisition will allow Integra to further develop innovative products to address unmet needs in neurosurgery, thus helping surgeons improve the standard of care, and in turn, boost the sales of regenerative medicines. Such developments are expected to aid the growth of the regenerative medicine industry globally in the forecast period.
Market Breakup by Technology, Application, and Regions:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global regenerative medicine market are Novartis AG, Vericel, Mimedx Group, Integra Lifesciences, Stryker, Wright Medical, Spark Therapeutics, Osiris Therapeutics, Kite Pharma (Subsidiary of Gilead Sciences), and Organogenesis, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
EMR is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.
At EMR, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.